Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
17.20
1.78
Vedl
223.40
Tata Stl
125.30
19.90
Axis Ban
994.40
23.38
Power Gr
199.00
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Lupin Limited
Lupin Limited
Sector:Pharmaceuticals
Pharmaceuticals - Bulk Drugs
BSE:
500257
NSE:
LUPIN
Bloomberg:
LPC@IN
Reuters:
LUPN.BO
Market Lot: 1
Face Value: 2
ISIN Demat: INE326A01037
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
08-Mar-2022
Lupin signs Mary Kom as brand ambassador for Shakti initiative
IRIS
09-Feb-2022
Lupin gets USFDA's nod for Arformoterol Tartrate Inhalation Solution
IRIS
28-Jan-2022
Lupin signs promotional agreement with Exeltis
IRIS
18-Jan-2022
Lupin gets nod to acquire portfolio of brands of Anglo-French Drugs & Industries
IRIS
14-Dec-2021
Lupin's Goa manufacturing plant gets EIR from USFDA
IRIS
06-Dec-2021
Lupin enters into pact with Biomm
IRIS
29-Sep-2021
Lupin launches Droxidopa Capsules in United States
IRIS
07-Sep-2021
Lupin and TB Alliance announce commercial partnership for new therapy
IRIS
25-Aug-2021
Lupin arm launches Luforbec for asthma and COPD treatment in UK
IRIS
16-Aug-2021
Lupin receives tentative USFDA nod for Brivaracetam Tablets
IRIS
17-Jun-2021
Lupin receives USFDA nod for Sevelamer Hydrochloride Tablets
IRIS
07-Jun-2021
Lupin launches Digital Asthma Educator platform
IRIS
07-Jun-2021
Lupin receives USFDA nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
IRIS
04-Jun-2021
Lupin launches authorized generic version of Brovana in United States
IRIS
03-Jun-2021
Lupin to enter digital helthcare space in India
IRIS
03-Jun-2021
Lupin announces USFDA acceptance for Pegfilgrastim Biosimilar application
IRIS
27-May-2021
Lupin receives payment of USD 50 mn from Boehringer Ingelheim
IRIS
10-May-2021
Lupin enters into licensing agreement with Lilly
IRIS
23-Apr-2021
Lupin incorporates wholly owned subsidiary in USA
IRIS
24-Mar-2021
LupinLife partners with Uttarakhand Police to promote Hand Hygiene at Kumbh Mela 2021
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer
Recent News